Document Classification

Section Type: RESULTS

Text: Within each group, the analysis demonstrated statistically significant improvements in both VAS and DASH within the prolotherapy group with significant changes noted from baseline to 3 months (VAS : 2. 38 ; 95 % confidence interval [95 % CI] 1. 04-3. 71, P =. 004 and DASH : 19. 89 ; 95 % CI 5. 73-34. 04, P =. 01), and baseline to 6 months (VAS : 2. 63 ; 95 % CI 0. 61-4. 62, P =. 017 and DASH : 21. 76 ; 9 % CI 7. 43-36. 09, P =. 009) after initial treatment, as well as in the QVAS from baseline to 3 months.